A significant breakthrough in cancer study is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential cancer protector protein is frequently inactivated in many kinds of malignancies, https://yoursocialpeople.com/story7446581/vhh-fragments-reactivate-p53-new-promising-approach-for-tumor-therapy